Page 3 - Sohini Das

Bajaj Auto posts highest ever quarterly revenue and PAT in Q2FY26

Around 20% of domestic revenues now come from electric vehicle business

Exponent Energy targets 2-2.5 million 3Ws with 24-hour EV retrofit

Backed by Hero MotoCorp's Pawan Munjal, Bengaluru-based Exponent Energy's 'Oto' technology can convert ICE three-wheelers to EVs in 24 hours, targeting 2-2.5 million conversions nationwide

Lupin Q2 PAT rises 73% on strong growth across key global markets

Lupin's consolidated profit rose 73% YoY to Rs 1,478 crore in Q2 FY26, led by robust sales in India and the US and higher margins from an improved product mix

Zydus PAT up 38% on strong India, US growth; board okays ₹5K cr fundraise

Zydus Lifesciences reported a 17% YoY rise in revenue to Rs 6,123 crore and a 38% jump in profit to Rs 1,258.6 crore in Q2 FY26, driven by India and US formulations performance

Sun Pharma Q2 net profit rises 2.5% to ₹3,118 crore on India, EM growth

Sun Pharma's Q2FY26 profit rose to Rs 3,118 crore as India, emerging markets, and rest of world drove growth; US revenues fell 4.1% despite strong gains in innovative medicines

M&M to sell entire 3.45% stake in RBL Bank via ₹682-cr block deal

The automaker's full exit from RBL Bank via a Rs 682 crore block deal brings a 64 per cent return on its year-old investment

M&M Q2 results: Profit rises 16% on strong auto and farm showing

The company reported consolidated PAT of ₹3,673 crore and 22% revenue growth in Q2 FY26, led by robust SUV sales, record tractor volumes, and higher margins across segments

'Bumper' October as two-wheeler retail sales top 2.8 million units

Hero MotoCorp nears 1 million retail sales, Bajaj tops EV chart as strong rural demand and GST boost lift festive momentum

GST 2.0 drives two-wheeler owners to car showrooms, boosts Maruti

GST 2.0 price cuts are bringing a new set of first-time car buyers into Maruti showrooms, with small car bookings rising sharply and a focused campaign launched to ease financing

October car retail outpaces OEM dispatches to dealers, aided by GST reforms

Retail sales, however, outpaced wholesales as vehicles continued to move swiftly out of showrooms

USFDA's new biosimilar norms to woo more players, fast-track mkt entry

Indian cos like Biocon, DRL, Intas, Lupin stand to benefit from the proposed move

Achin Gupta to succeed Umang Vohra as Cipla MD & GCEO from April 2026

Umang Vohra joined Cipla in 2015 as global chief financial and strategy officer and thereafter served as the company's MD & GCEO since 2016

Results preview: Pharma sales may be up 9-10% in Q2 on robust domestic biz

Domestic business and exports are expected to be a shot in the arm; hospitals and diagnostics to lag

This is the start of Hyundai India's next phase of growth: Tarun Garg

Hyundai veteran Tarun Garg will succeed Unsoo Kim as MD & CEO from Jan 1, 2026, marking a new chapter in the automaker's India journey

Q2 results preview: Robust volumes likely drove auto sector growth

But margins may have lost traction due to higher discounts, ad spends

Electric PV sales more than double in September; Tata Motors leads

New entrant Tesla also retailed 64 vehicles in September, data from the Federation of Automobile Dealers Associations (Fada) showed

A deadly dose of neglect: Bitter truth behind cough syrup scare

Bottled negligence: DEG contamination exposes gaps in inspections, leaving pharma units from Gujarat to Kerala under the microscope

Super-specialty hospitals may benefit from CGHS rate revision: Analysts

The new rules introduce a multi-dimensional rate structure based on three key parameters

Mercedes clocks best ever Navaratri with retail sales of 2,500 cars

After a sluggish July-August, Mercedes-Benz India posts record Navratri sales on GST cut boost; entry-level models lag but GLA under Rs 50 lakh may revive demand

Analysts expect Indian drugmakers to strike US deals to avoid tariff blow

If Sun Pharma is able to strike a Pfizer-like deal, it may avoid US tariff in near term, say experts